Patients with refractory Crohn’s disease who previously received ustekinumab experienced clinical and endoscopic improvements ...

In the past week, Johnson & Johnson unveiled a series of positive clinical updates and regulatory milestones for key pipeline ...

Alvotech’s inflammation-targeting biosimilar AVT05 has been rejected by the U.S. Food and Drug Administration (FDA) because ...

Shane Brouse has learned that psoriasis is more than a skin condition. The effects can be debilitating for some. When it ...

The CMS has finalized the first cycle of drug price negotiations under the IRA, establishing precedent for improved ...